Understanding opioid misuse in cancer patients
Prevalence of Opioid Misuse in Patients with Cancer
Rigshospitalet, Denmark · NCT06489769
This study looks at how many cancer patients in palliative care might misuse opioids and how this affects their quality of life and other health factors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rigshospitalet, Denmark (other) |
| Locations | 1 site (Copenhagen, København Ø.) |
| Trial ID | NCT06489769 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the prevalence of opioid misuse among cancer patients receiving palliative care in Denmark. It will utilize the Pain Medication Questionnaire (PMQ) and the Opioid Risk Tool (ORT) to assess misuse risk and correlate these scores with factors such as opioid consumption, substance use, and mental health. The study will also explore the relationship between opioid misuse risk and health-related quality of life. By focusing on a population that is often overlooked in terms of opioid misuse, this research seeks to fill a critical gap in the understanding of pain management in cancer care.
Who should consider this trial
Good fit: Ideal candidates for this study are outpatients aged 18 and older who are being treated with opioids for cancer-related pain.
Not a fit: Patients who do not speak Danish, have severe cognitive dysfunction, or are not currently treated with opioids will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies and reduced opioid misuse in cancer patients.
How similar studies have performed: While previous studies have explored opioid misuse in cancer patients, this study's specific focus on a Danish population and its methodology is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Outpatients ≥ 18 years, * patients who are treated with opioids due to cancer-related pain. Exclusion Criteria: * Patients who do not master the Danish language in speech and writing, * Patients who have severe cognitive dysfunction, * Patients who are not treated with opioids, * Patients who refused to participate in the study.
Where this trial is running
Copenhagen, København Ø.
- Rigshospitalet — Copenhagen, København Ø., Denmark (RECRUITING)
Study contacts
- Principal investigator: Geana Kurita, PHD — Rigshospitalet, Denmark
- Study coordinator: Geana Kurita, Professor
- Email: geana.kurita@regionh.dk
- Phone: +4535454797
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Opioid Use, Opioid Misuse, Pain, Cancer Pain